{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:14:52Z","timestamp":1787764492945,"version":"build-2784847793"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,8,2]],"date-time":"2010-08-02T00:00:00Z","timestamp":1280707200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>Patients with thalassemia major accumulate body iron over time as a consequence of continuous red blood cell transfusions which cause hepatic, endocrine, and cardiac complications. Despite the availability of three iron chelators, some patients fail to respond adequately to monotherapy with any of them. Combination therapy, consisting in the use of two chelators on the same day, has been introduced to increase the efficacy and to induce negative iron balance in patients with severe iron overload. Extensive long\u2010term experience has shown that combined chelation with deferiprone and deferoxamine (DFO) rapidly reduces liver iron, serum ferritin, and myocardial siderosis, improves cardiac function, reverses and prevents endocrine complications, reduces cardiac mortality, and improves survival. Side effects, though significant, are manageable if properly monitored. Preliminary promising results have been obtained using combined chelation with deferasirox and DFO. As more drug combination regimes are evaluated, it should be possible to better tailor iron chelation to the needs of the patients, minimizing toxicity and maximizing efficacy throughout life.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2010.05591.x","type":"journal-article","created":{"date-parts":[[2010,8,2]],"date-time":"2010-08-02T22:38:48Z","timestamp":1280788728000},"page":"79-86","source":"Crossref","is-referenced-by-count":55,"title":["Combined iron chelation therapy"],"prefix":"10.1111","volume":"1202","author":[{"given":"Renzo","family":"Galanello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Campus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Danjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,2]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.739"},{"key":"e_1_2_9_3_2","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna\u2010Pignatti C.","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3167"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2933"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321404"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3280"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000243801"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01002.x"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000243800"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/S1565363303000128"},{"key":"e_1_2_9_12_2","unstructured":"GradyR.W.et al.1999.Iron Chelation therapy: a better approach [abstract]. InProceedings of the 7th International Conference on Thalassaemia and the Hemoglobinopathies. Bangkok Thailand."},{"key":"e_1_2_9_13_2","first-page":"241a","article-title":"Combinations of desferrioxamine and deferiprone markedly enhance iron excretion [abstract]","volume":"100","author":"Grady R.W.","year":"2002","journal-title":"Blood"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.792"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070823"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02357-6"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/10976640600698155"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-10-12"},{"key":"e_1_2_9_19_2","first-page":"1309","article-title":"Combined therapy with deferiprone and desferrioxamine in thalassemia major","volume":"90","author":"Origa R.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0820-0"},{"key":"e_1_2_9_21_2","first-page":"55","article-title":"Successful recovery of acute hemosiderotic heart failure in beta\u2010thalassemia major treated with a combined regimen of desferrioxamine and deferiprone","volume":"91","author":"Tavecchia L.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_9_22_2","first-page":"353","article-title":"Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia","volume":"84","author":"Tsironi M.","year":"2005","journal-title":"Ann. Hematol."},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2006.08.006"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-016949"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.648790"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000037225.92759.A7"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-11-20"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0471-2"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07970.x"},{"key":"e_1_2_9_30_2","first-page":"21","article-title":"Comparative efficacy of desferrioxamine, deferiprone and in combination on iron chelation in thalassemic children","volume":"41","author":"Gomber S.","year":"2004","journal-title":"Indian Pediatr."},{"key":"e_1_2_9_31_2","first-page":"517a","article-title":"Efficacy of combined chelation therapy with subcutaneous desferrioxamine and oral deferiprone in patients with thalassemia major [abstract]","volume":"102","author":"Francis S.","year":"2003","journal-title":"Blood"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.11.002"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02258-5"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04240.x"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200550"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200407000-00011"},{"key":"e_1_2_9_37_2","first-page":"493","article-title":"Combined oral and parenteral iron chelation in beta thalassaemia major","volume":"55","author":"Balveer K.","year":"2000","journal-title":"Med. J. Malaysia"},{"key":"e_1_2_9_38_2","doi-asserted-by":"crossref","first-page":"28b","DOI":"10.1182\/blood.V104.11.3766.3766","article-title":"Efficient iron chelation resulting in improved myocardial performance with combined desferrioxamine and deferiprone in beta thalassemia major patients [abstract]","volume":"104","author":"Pathare A.V.","year":"2004","journal-title":"Blood"},{"key":"e_1_2_9_39_2","first-page":"79","article-title":"Combined chelation therapy in patients with thalassemia major: a fast and effective method of reducing ferritin levels and cardiological complications [abstract]","volume":"3","author":"Farmaki K.","year":"2002","journal-title":"Hematol. J."},{"key":"e_1_2_9_40_2","first-page":"1423","article-title":"Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion","volume":"88","author":"Kattamis K.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318142b51e"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02683.x"},{"key":"e_1_2_9_43_2","first-page":"1187","article-title":"Survival of medically treated thalassemia patients in Cyprus,. Trends and risk factors over the period 1980\u20132004","volume":"91","author":"Telfer P.","year":"2006","journal-title":"Haematoloica"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.009118"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2009.01.002"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0075-z"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2004.10.003"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09740-4"},{"key":"e_1_2_9_49_2","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major; a retrospective analysis","volume":"88","author":"Piga A.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.035"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07234.x"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2010.05591.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2010.05591.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:28:12Z","timestamp":1695601692000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2010.05591.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1749-6632.2010.05591.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05591.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}